BJ HEALTH released its interim results, with a loss attributable to shareholders of HKD 29.236 million, a year-on-year decrease of 48.17%
BJ HEALTH released its interim results for the period ending June 30, 2025, with revenue of HKD 76.587 million, an increase of 4.47% year-on-year; the loss attributable to shareholders was HKD 29.236 million, a decrease of 48.17% year-on-year; basic loss per share was HKD 0.048. The revenue growth was mainly due to moderate growth in medical and elderly care products, particularly strong sales performance in the educational furniture product line
According to the Zhitong Finance APP, BJ HEALTH (02389) announced its interim results for the six months ending June 30, 2025, with the group achieving revenue of HKD 76.587 million, an increase of 4.47% year-on-year; the loss attributable to the parent company was HKD 29.236 million, a decrease of 48.17% year-on-year; basic loss per share was HKD 0.048.
The announcement stated that the increase in revenue was mainly due to the moderate growth in sales revenue from medical and elderly care products and elderly care services. The revenue increase in the medical and elderly care products segment was primarily due to the effectiveness of the group's earlier efforts to develop a new line of educational furniture products, with related sales increasing year-on-year enough to offset the decline in sales of hospital furniture and elderly care furniture. The customers for educational furniture are major domestic colleges and universities, with strong cash flow and low bad debt risk. The increase in elderly care service revenue was mainly due to the rise in admission rates
